Your browser doesn't support javascript.
loading
A single-arm feasibility phase II study of EMF (erlotinib + methotrexate + 5-fluorouracil) regimen in platinum-refractory recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC).
Baa, Annie Kanchan; Sharma, Atul; Bhaskar, Suman; Biswas, Ahitagni; JeeBharti, Sacchidanand; Thakar, Alok; Kumar, Rajeev; Pramanik, Raja.
Afiliação
  • Baa AK; Department of Medical Oncology, Dr B. R. A. Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi 110029, India.
  • Sharma A; Department of Medical Oncology, Dr B. R. A. Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi 110029, India.
  • Bhaskar S; Department of Radiation Oncology, Dr B. R. A. Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi 110029, India.
  • Biswas A; Department of Radiation Oncology, Dr B. R. A. Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi 110029, India.
  • JeeBharti S; Department of Oncoanesthesia and Palliative Medicine, Dr B. R. A. Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi 110 029, India.
  • Thakar A; Department of Head and Neck Surgery, All India Institute of Medical Sciences, New Delhi 110 029, India.
  • Kumar R; Department of Head and Neck Surgery, All India Institute of Medical Sciences, New Delhi 110 029, India.
  • Pramanik R; Department of Medical Oncology, Dr B. R. A. Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi 110029, India.
Ecancermedicalscience ; 16: 1451, 2022.
Article em En | MEDLINE | ID: mdl-36405947

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Aspecto: Patient_preference Idioma: En Revista: Ecancermedicalscience Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Índia País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Aspecto: Patient_preference Idioma: En Revista: Ecancermedicalscience Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Índia País de publicação: Reino Unido